Zymvol Raises €3M to Transform Enzyme Development and Accelerate Global Expansion in Biotech Innovation
Barcelona-based biotech firm Zymvol has announced a successful seed funding round, securing €3 million to further its mission of revolutionizing enzyme discovery and engineering. The funding, led by venture capital firms Faber Ventures, Elaia Partners, and Übermorgen Ventures, positions Zymvol to accelerate its market expansion and enhance its cutting-edge technology. Transforming the Enzyme Development Process…
